Early experience with robot-assisted laparoscopic hepatobiliary and pancreatic surgery in Singapore: single-institution experience with 20 consecutive patients.
- Author:
Brian Kp GOH
1
;
Ser-Yee LEE
1
;
Chung-Yip CHAN
1
;
Jen-San WONG
1
;
Peng-Chung CHEOW
1
;
Alexander Yf CHUNG
1
;
London Lpj OOI
1
Author Information
- Publication Type:Journal Article
- Keywords: robotic hepatectomy; robotic hepatobiliary surgery; robotic liver resection; robotic pancreatectomy; robotic pancreatic resection
- MeSH: Adult; Aged; Bile Ducts; surgery; Cholecystectomy; Female; Hepatectomy; Humans; Laparoscopy; Male; Middle Aged; Operative Time; Pancreas; surgery; Pancreatectomy; Postoperative Complications; etiology; Reoperation; Retrospective Studies; Robotic Surgical Procedures; Singapore; Young Adult
- From:Singapore medical journal 2018;59(3):133-138
- CountrySingapore
- Language:English
-
Abstract:
INTRODUCTIONExperience with robot-assisted laparoscopic (RAL) hepatobiliary and pancreatic (HPB) surgery remains limited worldwide. In this study, we report our early experience with RAL HPB surgery in Singapore.
METHODSA retrospective review of the first 20 consecutive patients who underwent RAL HPB surgery at a single institution over a 34-month period from February 2013 to November 2015 was conducted. The 20 cases were performed by three principal surgeons, of which 17 (85.0%) were performed by a single surgeon.
RESULTSThe median age of patients was 56 (range 22-75) years and median tumour size was 4.0 (range 1.2-7.5) cm. The surgeries performed included left-sided pancreatectomies (n = 10), hepatectomies (n = 7), triple bypass with bile duct exploration for obstructing pancreatic head cancer with choledocholithiasis (n = 1), cholecystectomy for Mirizzi's syndrome (n = 1) and gastric resection for gastrointestinal stromal tumour (n = 1). The median operation time was 445 (range 80-825) minutes and median blood loss was 350 (range 0-1,200) mL. There was only 1 (5%) open conversion. There were 2 (10.0%) major morbidities (> Grade II on the Clavien-Dindo classification) and no 30-day/in-hospital mortalities. There was no reoperation for postoperative complications. The median postoperative stay was 5.5 (range 3-22) days.
CONCLUSIONOur initial experience confirms the feasibility and safety of RAL HPB surgery.
